Navigation Links
Germany Hosts World Leading Medical Industry Fair
Date:11/13/2007

DUSSELDORF, Germany, November 13 /PRNewswire/ -- MEDICA is the world's leading medical industry trade fair. Over 2,000 international exhibitors will gather here, from November 14th-17th, to present new advances and technologies for in-patient and out-patient care.

Germany's strengths in medical devices go beyond possessing Europe's largest market and a legacy of great scientific discovery. Rather, the German government is working to enhance research and development (R&D) and therefore ensure the industry's staying power. As part of Germany's "high-tech strategy," the country is making EUR800 million available for research and development in health research and medical technologies through the end of 2009.

In 2006, EUR21 billion were spent on medical devices in Germany making the country Europe's largest medical devices market, and it is growing. In the same year, domestic sales in the German medical devices industry brought in EUR15.9 billion, an increase of 8.1% over the previous year. Export sales also increased hitting a total of EUR10.2 billion in 2006-an improvement of 11.1% over the previous year and moving Germany's rank to second in medical devices exports.

The German medical device industry has major players such as Siemens Medical Solutions and Fresenius AG that are among the world's top 10 in the industry. Besides these leaders there are many small and mid-sized companies that are market leaders in their respective sub-segments. Market conditions such as Germany's track record in precision production and its excellent R&D landscape make it an attractive place for foreign medical devices companies. For example, leading international companies, such as Johnson & Johnson and GE Healthcare Technologies Inc. are major investors in Germany.

The country's demographic development combined with its high standard of health care also leads it to demand world-class medical devices. Nearly one-fifth of the German population is over age 65. This fact has meant a growing sophistication and commercialization of healthcare and homecare products and services, with positive returns for investors.

"We look forward to MEDICA as it is both one of the world's biggest gatherings of medical devices experts and a chance to educate potential investors about the many advantages that Germany offers pioneering companies," notes Dr. Nicola Henneberg, Senior Manager for Medical Devices at Invest in Germany.

Invest in Germany is the inward investment promotion agency of the Federal Republic of Germany. Its mandate is to promote Germany as an attractive business location. Invest in Germany provides investors with comprehensive support from site selection to the implementa-tion of investment decisions.

Media Contact:

Eva Henkel

Invest in Germany

Phone: +49-30-200099-173

Fax: +49-30-200099-111

Email: henkel@invest-in-germany.com

http://www.invest-in-germany.com


'/>"/>
SOURCE Invest in Germany
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
3. Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
4. Pharsight Hosts Fourth Annual PKS User Group Meeting
5. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
6. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
7. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
8. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
9. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
10. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
11. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
Breaking Biology Technology:
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):